Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 19;10(6):e5949. doi: 10.1002/ccr3.5949

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Data of Asian Working Group for Sarcopenia 2019 consensus diagnostic criteria. The criteria for low appendicular skeletal muscle mass is <5.7 kg/m² in women by bioelectrical impedance analysis; criteria for low muscle strength is defined as hand grip strength <18 kg for women; criteria for low physical performance are 6‐meter walking speed <1.0 m/sec. R‐THP‐COP, rituximab, pirarubicin, cyclophosphamide, prednisolone; Pola‐BR, polatuzumab vedotin, bendamustine, rituximab; R‐GDC, rituximab, gemcitabine, dexamethasone, carboplatin. , 30 Gy/10 fractions

Inline graphic — Data of Asian Working Group for Sarcopenia 2019 consensus diagnostic criteria. The criteria for low appendicular skeletal muscle mass is <5.7 kg/m² in women by bioelectrical impedance analysis; criteria for low muscle strength is defined as hand grip strength <18 kg for women; criteria for low physical performance are 6‐meter walking speed <1.0 m/sec. R‐THP‐COP, rituximab, pirarubicin, cyclophosphamide, prednisolone; Pola‐BR, polatuzumab vedotin, bendamustine, rituximab; R‐GDC, rituximab, gemcitabine, dexamethasone, carboplatin. , 30 Gy/10 fractions